Brand Performance logo

Vicks

Cold and runny nose medicines
to receive information about changes in the popularity of this brand.

Vicks ranks 17th of 35 brands in the Cold and runny nose medicines category with a 1.47% share over the last four weeks.

The category leader is Gripex with a 15.16% share.

Its monthly share for September 2026 was 1.45%, compared with 1.16% the month before.

Its highest monthly share in the period shown, 2.00%, came in July 2026.

Data comes from the shopping lists of Listonic and Moja Gazetka app users and is updated weekly.

BRAND CHARTS
Udział procentowy marek w kategorii Cold and runny nose medicines
MarkaUdział procentowy
Gripex15.16%
Rutinoscorbin11.52%
Nasivin8.84%
Strepsils6.63%
Fervex6.14%
Tantum Verde5.23%
Theraflu5.02%
Neosine5.01%
Otrivin4.61%
Sudafed4.34%
Solpadeine4.18%
Herbapect2.31%
Rutinacea2.11%
Xylometazolin Teva2.08%
Cholinex2.05%
Acatar2.04%
Vicks1.47%
Xylogel1.37%
Sinecod1.33%
Mucosolvan1.21%
Scorbolamid1.14%
Flegamina1.13%
Coldrex1.04%
Cerutin0.69%
Aspirin C0.66%
Sterimar0.53%
Nasic0.50%
Febrisan0.44%
Septolete0.42%
Renopuren0.36%
Neo-angin0.27%
Flegamax0.12%
Tabcin Trend0.05%
Talcid0.01%
Alka-seltzer0.00%

Brand Vicks percentage share in the category Cold and runny nose medicines in the last month

The chart shows data for the 4 weeks leading up to the selected date. The information is updated every Monday and includes data up to Sunday.
1.47%Vicks
ALL BRANDS
Historical market share of brands in the Cold and runny nose medicines category (monthly)
MonthAlka-seltzerAspirin CCerutinCholinexColdrexFebrisanFervexFlegaminaGripexHerbapectNeo-anginNeosineRutinaceaRutinoscorbinScorbolamidSeptoleteStrepsilsSudafedTalcidTherafluVicksRenopurenSolpadeineTabcin TrendTantum VerdeMucosolvanAcatarNasivinOtrivinSterimarXylometazolin TevaFlegamaxXylogelSinecodNasic
October 20240.00%0.51%0.39%1.48%0.54%0.29%3.29%1.55%8.81%1.43%0.22%3.50%1.29%17.57%0.71%0.18%3.71%2.27%0.00%3.40%1.01%0.31%1.59%0.03%3.12%1.21%1.43%4.13%32.84%0.27%0.88%0.10%0.54%1.13%0.28%
November 20240.01%0.52%0.52%1.55%0.52%0.29%3.36%1.35%8.63%1.60%0.37%3.89%1.46%19.86%0.98%0.20%3.86%2.00%0.00%3.38%0.98%0.33%1.55%0.04%3.25%1.38%1.50%4.20%28.92%0.28%1.01%0.08%0.85%1.06%0.24%
December 20240.00%1.13%0.58%2.12%0.70%0.48%5.37%2.53%14.27%2.52%0.34%5.52%1.73%7.76%1.30%0.30%6.54%3.95%0.00%6.35%1.41%0.49%2.57%0.05%4.28%2.01%2.09%7.32%10.03%0.32%1.67%0.42%1.17%2.21%0.47%
January 20250.01%1.15%0.82%2.22%1.09%0.40%6.04%2.60%14.52%2.50%0.39%7.50%2.07%9.47%1.46%0.30%6.44%3.75%0.00%6.17%1.35%0.62%2.77%0.03%5.43%1.99%1.87%7.27%4.19%0.46%1.56%0.21%0.95%1.95%0.45%
February 20250.00%1.29%0.80%2.46%0.82%0.49%5.09%2.62%15.13%2.49%0.31%7.39%2.02%8.98%1.35%0.29%6.44%3.90%0.02%6.05%1.43%0.72%2.43%0.05%5.17%2.46%2.27%7.08%3.93%0.39%1.55%0.31%1.50%2.25%0.54%
March 20250.00%0.92%0.82%2.03%0.74%0.52%5.02%2.59%14.12%2.37%0.36%7.31%2.35%8.84%1.10%0.48%6.73%3.96%0.00%6.06%1.39%0.46%2.59%0.06%5.20%2.09%2.57%8.21%4.42%0.36%1.77%0.24%1.65%2.17%0.50%
April 20250.00%0.74%0.74%2.44%0.66%0.37%5.07%1.78%12.57%2.13%0.37%4.91%2.02%9.40%1.30%0.50%7.28%4.97%0.00%5.42%0.74%0.40%3.77%0.08%5.69%2.10%3.13%8.82%5.07%0.69%2.36%0.19%1.65%1.97%0.64%
May 20250.00%0.71%0.71%3.03%0.71%0.40%4.94%1.57%12.97%1.54%0.59%4.63%1.82%9.23%0.90%0.59%7.29%4.23%0.00%5.16%1.30%0.31%4.17%0.00%5.34%2.35%2.62%10.47%4.88%0.49%2.16%0.06%2.35%2.22%0.28%
June 20250.00%0.83%0.49%3.12%0.76%0.42%3.67%1.63%12.51%2.11%0.28%3.85%1.80%8.35%1.00%0.73%7.52%5.09%0.00%4.26%1.07%0.42%4.68%0.00%6.10%1.87%2.98%10.50%6.06%0.35%3.05%0.10%1.87%1.91%0.62%
July 20250.00%1.01%0.48%2.94%0.44%0.44%4.35%1.98%12.34%1.27%0.44%4.30%1.45%8.56%1.10%0.44%7.99%4.52%0.00%4.08%0.97%0.09%7.20%0.09%6.67%1.19%2.50%10.36%5.05%0.61%2.72%0.09%1.84%2.02%0.48%
August 20250.00%0.75%1.00%2.40%0.93%0.32%5.77%1.51%14.59%0.97%0.47%3.62%1.68%10.29%1.04%0.61%7.89%4.44%0.04%4.70%1.08%0.47%6.27%0.07%5.23%1.11%2.29%8.14%5.48%0.54%2.62%0.11%1.61%1.33%0.65%
September 20250.00%0.84%0.66%2.64%1.04%0.29%6.23%1.54%16.06%1.52%0.31%6.25%2.34%9.46%1.37%0.47%6.88%4.06%0.00%6.58%1.33%0.47%3.05%0.04%5.28%1.02%2.31%8.87%4.04%0.41%1.56%0.08%1.45%1.21%0.35%
October 20250.00%1.00%0.76%2.49%0.94%0.39%6.16%1.43%16.53%2.18%0.41%5.61%2.43%10.25%1.25%0.45%6.90%3.57%0.00%7.14%1.31%0.61%2.80%0.06%4.63%1.22%2.37%6.55%4.37%0.73%2.18%0.33%1.29%1.33%0.33%
November 20250.00%0.98%0.74%2.26%0.63%0.28%5.09%1.48%13.18%1.70%0.35%4.83%2.20%20.12%1.35%0.30%6.74%3.35%0.00%5.92%1.48%0.44%2.72%0.00%4.61%1.61%2.11%6.37%3.87%0.61%1.61%0.07%1.24%1.28%0.48%
December 20250.00%0.75%0.52%1.78%0.63%0.35%4.99%1.52%12.77%1.66%0.27%4.69%1.65%25.85%0.93%0.24%5.26%2.93%0.00%5.95%1.19%0.53%2.72%0.04%4.25%1.88%2.14%6.02%3.56%0.41%1.49%0.14%1.10%1.53%0.27%
January 20260.00%1.12%0.73%2.35%1.00%0.30%6.37%1.93%15.78%2.07%0.36%6.06%2.01%10.53%1.22%0.49%5.52%3.34%0.00%7.04%1.42%0.44%2.89%0.07%4.93%1.71%2.61%7.48%4.22%0.47%1.64%0.32%1.63%1.69%0.27%
February 20260.00%1.06%0.98%2.27%0.82%0.46%6.06%1.60%14.94%2.42%0.32%6.06%1.80%9.98%0.91%0.41%6.11%4.37%0.00%6.45%1.58%0.67%2.66%0.06%4.57%2.42%2.21%7.99%4.29%0.52%1.75%0.15%1.65%2.14%0.37%
March 20260.00%0.90%0.73%2.27%0.85%0.44%5.98%1.61%13.75%2.30%0.27%5.84%1.42%9.72%0.95%0.56%6.74%4.18%0.00%6.01%1.27%0.71%3.22%0.02%4.52%2.34%2.78%8.30%5.03%0.46%1.93%0.15%2.08%2.05%0.61%
April 20260.00%0.85%0.61%2.77%1.04%0.45%5.14%1.84%11.96%2.24%0.29%4.96%1.81%8.93%1.23%0.51%6.45%4.72%0.00%5.49%0.99%0.61%4.29%0.00%4.77%2.45%2.56%9.97%5.25%0.75%2.16%0.27%1.39%2.80%0.48%
May 20260.00%0.95%0.72%2.96%0.46%0.04%5.01%2.01%12.75%1.67%0.23%4.82%1.40%9.48%0.72%0.34%6.56%3.98%0.00%4.36%1.10%0.53%5.50%0.00%5.39%1.97%2.09%10.62%5.39%0.57%2.50%0.11%2.28%2.96%0.53%
June 20260.00%1.08%0.68%2.87%0.75%0.12%3.50%1.60%11.54%2.19%0.24%3.06%1.72%8.51%0.61%0.94%7.69%4.68%0.00%3.69%1.03%0.40%6.46%0.09%6.35%1.39%3.55%11.82%5.17%0.99%2.80%0.02%1.95%2.04%0.49%
July 20260.05%1.02%0.69%2.48%0.76%0.20%3.75%1.22%10.98%1.73%0.25%3.88%1.94%10.01%0.87%0.54%6.69%4.22%0.00%4.11%2.00%0.28%6.21%0.00%7.69%1.50%2.33%11.42%5.32%0.72%2.20%0.12%1.94%2.38%0.53%
August 20260.00%0.88%0.93%2.23%0.64%0.22%4.61%0.99%10.66%2.47%0.12%3.75%1.73%11.08%0.90%0.57%7.22%3.54%0.03%3.98%1.16%0.40%8.07%0.00%6.83%1.33%2.45%10.04%5.24%0.80%2.52%0.14%2.33%1.43%0.69%
September 20260.00%0.68%0.68%2.10%1.04%0.46%6.21%1.13%15.12%2.30%0.27%5.11%2.13%11.45%1.14%0.40%6.67%4.30%0.01%5.20%1.45%0.41%3.97%0.05%5.07%1.12%2.11%8.69%4.59%0.55%2.00%0.15%1.45%1.48%0.52%

Percentage share of tagged brands in individual months

How the share of the selected brands in the Cold and runny nose medicines category has changed over the months
The method of counting additions changed in June 2026 – comparisons with periods before that date may not be fully reliable.
Show data up to:
Range:
Vicks
Others
Gripex
Rutinoscorbin
Nasivin
Strepsils
Fervex
Tantum Verde
Theraflu
Neosine
Otrivin
Sudafed
Solpadeine
Herbapect
Rutinacea
Xylometazolin Teva
Cholinex
Acatar
Xylogel
Sinecod
Mucosolvan
Scorbolamid
Flegamina
Coldrex
Cerutin
Aspirin C
Sterimar
Nasic
Febrisan
Septolete
Renopuren
Neo-angin
Flegamax
Tabcin Trend
Talcid
Alka-seltzer

Sources of additions to shopping lists

Shows the monthly share of sources from which users added products of the brand Vicks from the Cold and runny nose medicines category to shopping lists.
The method of counting additions changed in June 2026 – comparisons with periods before that date may not be fully reliable.
Show data up to:
Range:
Manual entry (organic)
Leaflets
Advertising
SUBCATEGORY CHARTS

Time to store

Shows how much time passes from adding a product from a given subcategory to a shopping list to the moment of purchase
85.9 h
Cold and runny nose medicines
Type Planned | Over 72 h
Products added well in advance and purchased during planned, less frequent shopping trips. The long time from list to purchase reflects a deliberate, cyclical decision.
Comparison with the other subcategories in “Health”
Condoms
Contact lenses
Heartburn medicines
Painkillers and anti-inflammatory drugs
Allergy medicines
Cold and runny nose medicines
Digestive medicines
54.8 h
69 h
73.1 h
76.5 h
78 h
85.9 h
86.6 h
Median of the Health category: 86.6 h
Medicines for herpes and skin problems
Dietary supplements and vitamins for adults
Antispasmodics
Dietary supplements and vitamins for children
Potency and libido medicines
Fertility drugs
99.2 h
103.6 h
125 h
135.6 h
287.7 h
783.6 h
Brand Loyalty Index (BLI) marki w kategorii Cold and runny nose medicines (miesięcznie)
MiesiącBLI (%)
2024-10-01T00:00:00100.00%
2024-11-01T00:00:00100.00%
2024-12-01T00:00:00100.00%
2025-01-01T00:00:00100.00%
2025-02-01T00:00:000.00%
2025-03-01T00:00:00100.00%
2025-04-01T00:00:0063.71%
2025-05-01T00:00:0059.87%
2025-06-01T00:00:0052.07%
2025-07-01T00:00:0042.88%
2025-08-01T00:00:0027.51%
2025-09-01T00:00:0037.38%
2025-10-01T00:00:000.00%
2025-11-01T00:00:000.00%
2025-12-01T00:00:000.00%
2026-01-01T00:00:000.00%
2026-02-01T00:00:000.00%
2026-03-01T00:00:000.00%
2026-04-01T00:00:000.00%
2026-05-01T00:00:000.00%
2026-06-01T00:00:000.00%
2026-07-01T00:00:000.00%
2026-08-01T00:00:000.00%
2026-09-01T00:00:0055.15%
-44.80%

BLI - Brand Loyalty Index

The Brand Loyalty Index (BLI) indicates the degree of Listonic app users attachment to individual brands. It shows what percentage of products in category Cold and runny nose medicines added to the Listonic shopping list are entered with the brand.
Show data up to:
Range:
Bezwzględna liczba dodań produktów z kategorii Cold and runny nose medicines (miesięcznie)
MiesiącDodania z markąWszystkie dodania z kategorii
2024-10-01T00:00:001034610346
2024-11-01T00:00:0095109510
2024-12-01T00:00:0077047704
2025-01-01T00:00:0067236723
2025-02-01T00:00:0061340
2025-03-01T00:00:0050205020
2025-04-01T00:00:0037645908
2025-05-01T00:00:0032395410
2025-06-01T00:00:0028865543
2025-07-01T00:00:0022785312
2025-08-01T00:00:00279010141
2025-09-01T00:00:00488213059
2025-10-01T00:00:0048990
2025-11-01T00:00:0045970
2025-12-01T00:00:0077600
2026-01-01T00:00:0059070
2026-02-01T00:00:0053830
2026-03-01T00:00:0040950
2026-04-01T00:00:0037530
2026-05-01T00:00:0026360
2026-06-01T00:00:0042550
2026-07-01T00:00:0060860
2026-08-01T00:00:0057860
2026-09-01T00:00:001034418756

Additions of a product from category Cold and runny nose medicines

Absolute data on adding products from category Cold and runny nose medicines with a brand compared to all additions from the category.
The method of counting additions changed in June 2026 – comparisons with periods before that date may not be fully reliable.
Show data up to:
Range:
Number of additions Cold and runny nose medicines
Number of additions Cold and runny nose medicines with the brand
The data for the analysis comes from shopping lists in Listonic and Moja Gazetka. The study has been supplemented with data from Moja Gazetka since October 2024.From June 2026 the method of counting additions has been refined: re-marking a product as to buy after it was previously checked off as bought (an "uncheck") now also counts as an addition to the list. This change affects data from June 2026 onwards – worth bearing in mind when comparing with earlier periods.
Is your brand missing from the comparison?
Want to increase your sales?Contact us